Development of Search Strategy for Peptide Inhibitors of Immune Checkpoints

S. V. Podlesnykh, D. V. Shanshin, E. A. Kolosova, D. E. Murashkin, O. N. Shaprova, D. N. Shcherbakov, Andrei Chapoval

Research output: Contribution to journalArticle

Abstract

Current strategy for the blockade of molecules inhibiting T-cell immunity, the immune checkpoints (ICP), such as CTLA-4, PD-1, and B7-H1(PD-L1), using monoclonal antibodies (mAbs), showed significant clinical effects in cancer immunotherapy. In this kind of therapy, antibodies do not kill tumor cells directly, but block inhibitory signals for T lymphocytes, resulting in activation of the immune response cascade that eliminate malignant cells and lead to tumor degradation. However, the mAb preparations have some limitations, and the development of new low-molecular-weight antagonists (for example, peptides) is an important issue. In this study, we used peptide microarrays and phage display libraries to search for peptides that interact with the immune checkpoints. We found peptides that specifically bind CTLA-4, PD-1, B7-1, B7-2 and B7-H1(PD-L1) which play important role in the regulation of the immune responses. These synthetic peptides can be applied to the development of new immunomodulating drugs for cancer immunotherapy.

Original languageEnglish (US)
Pages (from-to)150-157
Number of pages8
JournalRussian Journal of Bioorganic Chemistry
Volume44
Issue number2
DOIs
StatePublished - Mar 1 2018

Fingerprint

Peptides
T-cells
Immunotherapy
Tumors
Neoplasms
T-Lymphocytes
Peptide Library
Microarrays
Immunity
Molecular Weight
Chemical activation
Molecular weight
Monoclonal Antibodies
Cells
Degradation
Molecules
Antibodies
Pharmaceutical Preparations
Therapeutics

Keywords

  • co-stimulatory molecules
  • immune checkpoints
  • immune response
  • immunomodulation
  • immunotherapy
  • peptide microchips
  • phage display
  • synthetic peptides

ASJC Scopus subject areas

  • Biochemistry
  • Organic Chemistry

Cite this

Podlesnykh, S. V., Shanshin, D. V., Kolosova, E. A., Murashkin, D. E., Shaprova, O. N., Shcherbakov, D. N., & Chapoval, A. (2018). Development of Search Strategy for Peptide Inhibitors of Immune Checkpoints. Russian Journal of Bioorganic Chemistry, 44(2), 150-157. https://doi.org/10.1134/S1068162018020024

Development of Search Strategy for Peptide Inhibitors of Immune Checkpoints. / Podlesnykh, S. V.; Shanshin, D. V.; Kolosova, E. A.; Murashkin, D. E.; Shaprova, O. N.; Shcherbakov, D. N.; Chapoval, Andrei.

In: Russian Journal of Bioorganic Chemistry, Vol. 44, No. 2, 01.03.2018, p. 150-157.

Research output: Contribution to journalArticle

Podlesnykh, SV, Shanshin, DV, Kolosova, EA, Murashkin, DE, Shaprova, ON, Shcherbakov, DN & Chapoval, A 2018, 'Development of Search Strategy for Peptide Inhibitors of Immune Checkpoints', Russian Journal of Bioorganic Chemistry, vol. 44, no. 2, pp. 150-157. https://doi.org/10.1134/S1068162018020024
Podlesnykh SV, Shanshin DV, Kolosova EA, Murashkin DE, Shaprova ON, Shcherbakov DN et al. Development of Search Strategy for Peptide Inhibitors of Immune Checkpoints. Russian Journal of Bioorganic Chemistry. 2018 Mar 1;44(2):150-157. https://doi.org/10.1134/S1068162018020024
Podlesnykh, S. V. ; Shanshin, D. V. ; Kolosova, E. A. ; Murashkin, D. E. ; Shaprova, O. N. ; Shcherbakov, D. N. ; Chapoval, Andrei. / Development of Search Strategy for Peptide Inhibitors of Immune Checkpoints. In: Russian Journal of Bioorganic Chemistry. 2018 ; Vol. 44, No. 2. pp. 150-157.
@article{07b51c014e1c4935a499cd07bac4c3a4,
title = "Development of Search Strategy for Peptide Inhibitors of Immune Checkpoints",
abstract = "Current strategy for the blockade of molecules inhibiting T-cell immunity, the immune checkpoints (ICP), such as CTLA-4, PD-1, and B7-H1(PD-L1), using monoclonal antibodies (mAbs), showed significant clinical effects in cancer immunotherapy. In this kind of therapy, antibodies do not kill tumor cells directly, but block inhibitory signals for T lymphocytes, resulting in activation of the immune response cascade that eliminate malignant cells and lead to tumor degradation. However, the mAb preparations have some limitations, and the development of new low-molecular-weight antagonists (for example, peptides) is an important issue. In this study, we used peptide microarrays and phage display libraries to search for peptides that interact with the immune checkpoints. We found peptides that specifically bind CTLA-4, PD-1, B7-1, B7-2 and B7-H1(PD-L1) which play important role in the regulation of the immune responses. These synthetic peptides can be applied to the development of new immunomodulating drugs for cancer immunotherapy.",
keywords = "co-stimulatory molecules, immune checkpoints, immune response, immunomodulation, immunotherapy, peptide microchips, phage display, synthetic peptides",
author = "Podlesnykh, {S. V.} and Shanshin, {D. V.} and Kolosova, {E. A.} and Murashkin, {D. E.} and Shaprova, {O. N.} and Shcherbakov, {D. N.} and Andrei Chapoval",
year = "2018",
month = "3",
day = "1",
doi = "10.1134/S1068162018020024",
language = "English (US)",
volume = "44",
pages = "150--157",
journal = "Russian Journal of Bioorganic Chemistry",
issn = "1068-1620",
publisher = "Maik Nauka-Interperiodica Publishing",
number = "2",

}

TY - JOUR

T1 - Development of Search Strategy for Peptide Inhibitors of Immune Checkpoints

AU - Podlesnykh, S. V.

AU - Shanshin, D. V.

AU - Kolosova, E. A.

AU - Murashkin, D. E.

AU - Shaprova, O. N.

AU - Shcherbakov, D. N.

AU - Chapoval, Andrei

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Current strategy for the blockade of molecules inhibiting T-cell immunity, the immune checkpoints (ICP), such as CTLA-4, PD-1, and B7-H1(PD-L1), using monoclonal antibodies (mAbs), showed significant clinical effects in cancer immunotherapy. In this kind of therapy, antibodies do not kill tumor cells directly, but block inhibitory signals for T lymphocytes, resulting in activation of the immune response cascade that eliminate malignant cells and lead to tumor degradation. However, the mAb preparations have some limitations, and the development of new low-molecular-weight antagonists (for example, peptides) is an important issue. In this study, we used peptide microarrays and phage display libraries to search for peptides that interact with the immune checkpoints. We found peptides that specifically bind CTLA-4, PD-1, B7-1, B7-2 and B7-H1(PD-L1) which play important role in the regulation of the immune responses. These synthetic peptides can be applied to the development of new immunomodulating drugs for cancer immunotherapy.

AB - Current strategy for the blockade of molecules inhibiting T-cell immunity, the immune checkpoints (ICP), such as CTLA-4, PD-1, and B7-H1(PD-L1), using monoclonal antibodies (mAbs), showed significant clinical effects in cancer immunotherapy. In this kind of therapy, antibodies do not kill tumor cells directly, but block inhibitory signals for T lymphocytes, resulting in activation of the immune response cascade that eliminate malignant cells and lead to tumor degradation. However, the mAb preparations have some limitations, and the development of new low-molecular-weight antagonists (for example, peptides) is an important issue. In this study, we used peptide microarrays and phage display libraries to search for peptides that interact with the immune checkpoints. We found peptides that specifically bind CTLA-4, PD-1, B7-1, B7-2 and B7-H1(PD-L1) which play important role in the regulation of the immune responses. These synthetic peptides can be applied to the development of new immunomodulating drugs for cancer immunotherapy.

KW - co-stimulatory molecules

KW - immune checkpoints

KW - immune response

KW - immunomodulation

KW - immunotherapy

KW - peptide microchips

KW - phage display

KW - synthetic peptides

UR - http://www.scopus.com/inward/record.url?scp=85045690739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045690739&partnerID=8YFLogxK

U2 - 10.1134/S1068162018020024

DO - 10.1134/S1068162018020024

M3 - Article

AN - SCOPUS:85045690739

VL - 44

SP - 150

EP - 157

JO - Russian Journal of Bioorganic Chemistry

JF - Russian Journal of Bioorganic Chemistry

SN - 1068-1620

IS - 2

ER -